Neutropenic Fever Management

Definition and Clinical Presentation

Neutropenic fever is defined as a single oral temperature measurement of >38.3°C (101°F) or a temperature of >38.0°C (100.4°F) sustained over a 1-hour period in a patient with an absolute neutrophil count (ANC) <1000 cells/mm³, according to the Infectious Diseases Society of America 1, 2
Neutropenic patients often have minimal or absent signs of infection due to impaired inflammatory response, as noted by the World Journal of Emergency Surgery 3
Classic signs of inflammation (redness, swelling, purulence) may be diminished or absent in neutropenic patients, as reported by the Clinical Infectious Diseases journal 4
Fever may be the only sign of infection in neutropenic patients, as stated by the Clinical Infectious Diseases journal 2

Blood cultures are mandatory in all cases of suspected neutropenic fever (before antibiotic administration if possible), as recommended by the Clinical Infectious Diseases journal 4
Consider drawing blood cultures from both central venous catheter (if present) and peripheral vein, as suggested by the Clinical Infectious Diseases journal 4
Chest radiograph is indicated for patients with respiratory signs/symptoms, as recommended by the Clinical Infectious Diseases journal 4
Thorough examination of common infection sites is essential: oral cavity, skin (including catheter sites), lungs, perianal area, as noted by the Clinical Infectious Diseases journal 4, 2
Laboratory tests should include complete blood count with differential to confirm neutropenia, as recommended by the Clinical Infectious Diseases journal 1

Gram-positive bacteria account for approximately 60-70% of documented infections in neutropenic fever, as reported by the Clinical Infectious Diseases journal 1
Common gram-negative pathogens include E. coli, Klebsiella, Enterobacter, and Pseudomonas aeruginosa, as noted by the Clinical Infectious Diseases journal 2
Fungi (particularly Candida and Aspergillus) are rarely the cause of initial fever but become more common after the first week of neutropenia, as stated by the Clinical Infectious Diseases journal 2
The majority of neutropenic fever episodes have no identifiable source of infection despite thorough evaluation, as reported by the Clinical Infectious Diseases journal 1

Neutropenic fever requires urgent empirical antibiotic therapy (within 2 hours of presentation) regardless of whether a source is identified, as recommended by the Clinical Infectious Diseases journal 1
Neutropenic patients require broad-spectrum antibiotics with coverage for Pseudomonas and other gram-negative pathogens, as noted by the Clinical Infectious Diseases journal 5
Recommended empiric regimens for neutropenic fever include monotherapy with an antipseudomonal beta-lactam (cefepime, piperacillin-tazobactam, or a carbapenem), as suggested by the Clinical Infectious Diseases journal 5
For high-risk patients or those with signs of sepsis, vancomycin plus antipseudomonal coverage is recommended, as stated by the Clinical Infectious Diseases journal 5

In patients with hematologic malignancies, median time to defervescence with empirical antibiotics is 5 days, as reported by the Clinical Infectious Diseases journal 1
In patients with solid tumors, median time to defervescence is 2 days, as noted by the Clinical Infectious Diseases journal 1
Persistent fever in neutropenic patients may indicate resistant bacterial infection, fungal superinfection, non-infectious cause, or inadequate antibiotic levels, as stated by the Clinical Infectious Diseases journal 6, 7, 1